T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Chronic lymphocytic leukemia (CLL) is a B-cell malignancy that remains incurable despite recent treatment advances.
• The tumor microenvironment (TME) plays a critical role in CLL pathogenesis and progression through cellular crosstalk.
• T cells within the TME are implicated in CLL hallmarks like immune evasion and suppression.

Purpose of the Study:

• To investigate the role of T cells in CLL pathophysiology and their interactions within the TME.
• To understand the mechanisms behind T cell dysfunction in CLL.
• To explore T cell-targeted therapies for CLL management.

Main Methods:

• Analysis of T cell receptor gene repertoire and clonotypes in CLL patients.
• Phenotypic and gene expression profiling of T cells in the CLL microenvironment.
• Review of existing literature on T cell-TME interactions in CLL.

Main Results:

• CLL is associated with restricted T cell receptor repertoires and oligoclonal T cell expansions.
• T cells in CLL exhibit an "exhausted" phenotype and impaired anti-tumor activity.
• T cell dysfunction is linked to alterations in cytoskeleton and immune synapse formation, reversible upon T cell contact.

Conclusions:

• T cell dysfunction is a key feature of CLL, contributing to disease progression.
• The TME significantly influences T cell behavior and function in CLL.
• Targeting the T cell compartment, including CAR T cell therapy and immune checkpoint blockade, shows promise for CLL treatment.